Search Results - Ruopeng Su

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy by Lin Xia, Ruopeng Su, Zhiqiang An, Tong-Ming Fu, Wenxin Luo

    Published in Human Vaccines & Immunotherapeutics (2018-02-01)
    Get full text
    Article


  2. 2

    Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation by Ruopeng Su, Lei Chen, Zhou Jiang, Minghao Yu, Weiwei Zhang, Zehua Ma, Yiyi Ji, Kai Shen, Zhixiang Xin, Jun Qi, Wei Xue, Qi Wang, Qi Wang

    Published in Frontiers in Oncology (2022-08-01)
    Get full text
    Article


  3. 3

    Prognostic value of [18F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study by Ang Li, Kai Shen, Yiyi Ji, Weiwei Zhang, Bo Liu, Ruopeng Su, Xiang Zhou, Liang Dong, Yinjie Zhu, Baijun Dong, Jiahua Pan, Qi Wang, Wei Xue

    Published in Annals of Medicine (2024-12-01)
    Get full text
    Article


  4. 4

    The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemc... by Jiwei Huang, Ruopeng Su, Zeyu Chen, Shuai Jiang, Minfeng Chen, Yichu Yuan, Hailong Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Chancan Li, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Qiang Wei, Wei Xue

    Published in OncoImmunology (2022-12-01)
    Get full text
    Article


  5. 5

    Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study by Ruopeng Su, Zeyu Chen, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hailong Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue

    Published in Cancer Medicine (2023-05-01)
    Get full text
    Article


  6. 6

    The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer by Yiyi Ji, Weiwei Zhang, Kai Shen, Ruopeng Su, Xinyu Liu, Zehua Ma, Bo Liu, Cong Hu, Yizheng Xue, Zhixiang Xin, Yi Yang, Ang Li, Zhou Jiang, Na Jing, Helen He Zhu, Liang Dong, Yinjie Zhu, Baijun Dong, Jiahua Pan, Qi Wang, Wei Xue

    Published in Nature Communications (2023-11-01)
    Get full text
    Article


  7. 7

    Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study by Ruopeng Su, Tingxuan Huang, Liangyou Gu, Yige Bao, Zhihong Liu, Pinghong Dao, Lin Yao, Xiaoyi Hu, Guanghou Fu, Jitao Wu, Thibault Tricard, Guangyu Wu, Minfeng Chen, Chancan Li, Zhiyang Huang, Bing Zheng, Yonghui Chen, Wei Xue, Gang Guo, Pei Dong, Jiwei Huang, Jin Zhang

    Published in Cancer Medicine (2024-09-01)
    Get full text
    Article


Search Tools: